美國神經刺激裝置市場：2009年

美國神經刺激裝置市場：2009年 是由出版商Millennium Research Group在2009年02月所出版的。 這份英文市場調查報告書價格從美金4197起跳。

簡介

目錄

Abstract

The US market for neurostimulation devices, which includes spinal cord, deep brain, sacral nerve, vagus nerve, and gastric stimulation devices was valued at over $1 billion in 2008.

Table of Contents

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US NEUROSTIMULATION DEVICE MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Major Neurostimulation Indications
  • 1.2.2 Emerging Neurostimulation Indications
  • 1.2.3 Humanitarian Device Exemption
  • 1.2.4 Device Overview
    • 1.2.4.1 Spinal Cord Stimulation
    • 1.2.4.2 Deep Brain Stimulation
    • 1.2.4.3 Sacral Nerve Stimulation
    • 1.2.4.4 Vagus Nerve Stimulation
    • 1.2.4.5 Gastric Stimulation
  • 1.2.5 Market Forecast
    • 1.2.5.1 Economic Assumptions for the Forecast Period
    • 1.2.5.2 US Neurostimulation Device Market
    • 1.2.5.3 Market Drivers and Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Emerging Competitors

2.0 SPINAL CORD STIMULATION DEVICE MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Market Forecast
    • 2.2.1.1 Market by Implant Type: Initial Implants and Replacements
    • 2.2.1.2 Market by Device Type: Primary Cell and Rechargeable IPGs
    • 2.2.1.3 Emerging Spinal Cord Stimulation Indications
  • 2.2.2 Market Drivers and Limiters
• 2.3 Competitive Analysis

3.0 DEEP BRAIN STIMULATION DEVICE MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Market Forecast
    • 3.2.1.1 Newly Approved Indication: Obsessive Compulsive Disorder
    • 3.2.1.2 Market by Implant Type: Initial Implants and Replacements
    • 3.2.1.3 Market by Indication
    • 3.2.1.4 Emerging Deep Brain Stimulation Indications
  • 3.2.2 Market Drivers and Limiters
• 3.3 Competitive Analysis

4.0 SACRAL NERVE STIMULATION DEVICE MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Market Forecast
    • 4.2.1.1 Potential Expanded Indication: Fecal Incontinence
    • 4.2.1.2 Market by Implant Type: Initial Implants and Replacements
  • 4.2.2 Market Drivers and Limiters
• 4.3 Competitive Analysis

5.0 VAGUS NERVE STIMULATION DEVICE MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Market Forecast
    • 5.2.1.1 Market by Implant Type: Initial Implants and Replacements
    • 5.2.1.2 Emerging Vagus Nerve Stimulation Indications
  • 5.2.2 Market Drivers and Limiters
• 5.3 Competitive Analysis

6.0 GASTRIC STIMULATION DEVICE MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Market Forecast
    • 6.2.1.1 Market by Implant Type: Initial Implants and Replacements
    • 6.2.1.2 Emerging Gastric Stimulation Indication: Obesity Market Potential
  • 6.2.2 Market Drivers and Limiters
• 6.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Neurostimulation Device Market, US (US$), 2007 - 2013
• Exhibit 2: SCS Units, by Device Type, US, 2007 - 2013
• Exhibit 3: DBS Units, by Implant Type, as a % of Total, US, 2008
• Exhibit 4: SNS Device Market, by Indication, US (US$), 2007 - 2013
• Exhibit 5: VNS Units, by Indication, US, 2007 - 2013
• Exhibit 6: Gastric Stimulation Market, by Implant Type, US (US$), 2007 - 2013
• Exhibit 7: Current and Emerging Competitors in the Neurostimulation Device Market, 2008

CHAPTER 1: US NEUROSTIMULATION DEVICE MARKET

• Exhibit 8: Neurostimulation Device Market, US (US$), 2007 - 2013
• Exhibit 9: Approved and Emerging Neurostimulation Indications, by Treatment Method, US, 2008
• Exhibit 10: Neurostimulation Device Units, by Segment, US, 2007 - 2013
• Exhibit 11: Neurostimulation Device Unit Growth, by Segment, US, 2008 - 2013
• Exhibit 12: Neurostimulation Device Market, by Segment, US (US$), 2007 - 2013
• Exhibit 13: Neurostimulation Device Market Growth, by Segment, US, 2008 - 2013
• Exhibit 14: Drivers of the Neurostimulation Device Market, US
• Exhibit 15: Limiters of the Neurostimulation Device Market, US
• Exhibit 16: Leading Competitors in the Neurostimulation Market, by Segment, as a % of Total, US, 2008

CHAPTER 2: SPINAL CORD STIMULATION DEVICE MARKET

• Exhibit 17: SCS Device Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 18: SCS Device Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 19: SCS Units, by Implant and Device Type, US, 2007 - 2013
• Exhibit 20: SCS Unit Growth, by Implant and Device Type, US, 2008 - 2013
• Exhibit 21: SCS Units, by Implant and Device Type, as a % of Total, US, 2007 - 2013
• Exhibit 22: SCS Device ASPs, by Device Type, US (US$), 2007 - 2013
• Exhibit 23: SCS Device ASPs, by Implant Type, US (US$), 2007 - 2013
• Exhibit 24: SCS Device Market, by Implant and Device Type, US (US$), 2007 - 2013
• Exhibit 25: SCS Device Market Growth, by Implant and Device Type, US, 2008 - 2013
• Exhibit 26: SCS Device Market, by Implant and Device Type, as a % of Total, US, 2007 - 2013
• Exhibit 27: Drivers of the SCS Device Market, US
• Exhibit 28: Limiters of the SCS Device Market, US
• Exhibit 29: Leading Competitors in the SCS Device Market, as a % of Total, US, 2008

CHAPTER 3: DEEP BRAIN STIMULATION DEVICE MARKET

• Exhibit 30: DBS Device Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 31: DBS Device Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 32: DBS Units, by Implant Type and Indication, US, 2007 - 2013
• Exhibit 33: DBS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
• Exhibit 34: DBS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
• Exhibit 35: DBS Device ASPs, by Implant Type, US (US$), 2007 - 2013
• Exhibit 36: DBS Device Market, by Implant Type and Indication, US (US$), 2007 - 2013
• Exhibit 37: DBS Device Market Growth, by Implant Type and Indication, US, 2008 - 2013
• Exhibit 38: DBS Device Market, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
• Exhibit 39: Drivers of the DBS Device Market, US
• Exhibit 40: Limiters of the DBS Device Market, US

CHAPTER 4: SACRAL NERVE STIMULATION DEVICE MARKET

• Exhibit 41: SNS Device Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 42: SNS Device Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 43: SNS Units, by Implant Type and Indication, US, 2007 - 2013
• Exhibit 44: SNS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
• Exhibit 45: SNS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
• Exhibit 46: SNS ASPs, by Implant Type, US (US$), 2007 - 2013
• Exhibit 47: SNS Device Market, by Implant Type, US (US$), 2007 - 2013
• Exhibit 48: SNS Device Market, by Indication, US (US$), 2007 - 2013
• Exhibit 49: Drivers of the SNS Device Market, US
• Exhibit 50: Limiters of the SNS Device Market, US

CHAPTER 5: VAGUS NERVE STIMULATION DEVICE MARKET

• Exhibit 51: VNS Device Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 52: VNS Device Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 53: VNS Units, by Implant Type and Indication, US, 2007 - 2013
• Exhibit 54: VNS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
• Exhibit 55: VNS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
• Exhibit 56: VNS ASPs, by Implant Type, US (US$), 2007 - 2013
• Exhibit 57: VNS Device Market, by Implant Type and Indication, US, 2007 - 2013
• Exhibit 58: VNS Device Market Growth, by Implant Type and Indication, US, 2008 - 2013
• Exhibit 59: VNS Market, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
• Exhibit 60: Drivers of the VNS Device Market, US
• Exhibit 61: Limiters of the VNS Device Market, US

CHAPTER 6: GASTRIC STIMULATION DEVICE MARKET

• Exhibit 62: Gastric Stimulation Device Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 63: Gastric Stimulation Device Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 64: Gastric Stimulator Units, by Implant Type, US, 2007 - 2013
• Exhibit 65: Gastric Stimulator ASPs, by Implant Type, US (US$), 2007 - 2013
• Exhibit 66: Gastric Stimulation Device Market, by Implant Type, US (US$), 2007 - 2013
• Exhibit 67: Obesity Prevalence, by Obesity Class, US, 2007 - 2013
• Exhibit 68: Eligible Population upon Initial Approval of Neurostimulation, by Obesity Class, US, 2007 - 2013
• Exhibit 69: Drivers of the Gastric Stimulation Device Market, US
• Exhibit 70: Limiters of the Gastric Stimulation Device Market, US

APPENDIX B: SUPPLEMENTAL EXHIBITS

• Exhibit 71: Neurostimulation Device Market, US (US$), 2007 - 2013 (Detailed Format)
• Exhibit 72: SCS Units, by Device Type, US, 2007 - 2013 (Detailed Format)
• Exhibit 73: DBS Units, by Implant Type, as a % of Total, US, 2008 (Detailed Format)
• Exhibit 74: SNS Device Market, by Indication, US (US$), 2007 - 2013 (Detailed Format)
• Exhibit 75: VNS Units, by Indication, US, 2007 - 2013 (Detailed Format)
• Exhibit 76: Gastric Stimulation Market, by Implant Type, US (US$), 2007 - 2013 (Detailed Format)

相關商品

矚目市場調查報告書

在神經刺激設備上的進步

Advances in Neurostimulators

價格 : US $ 6500

出版日期 : 2010年04月

Millennium Research Group發行的醫療設備相關市場調查報告書

玻尿酸黏稠補充療法的全球市場：2012年

Global Markets for Hyaluronic Acid Viscosupplementation 2012

價格 : US $ 6995

出版日期 : 2011年12月

美國的外傷治療裝置市場：2012年

US Markets for Trauma Devices 2012

價格 : US $ 6995

出版日期 : 2011年12月

美國的心血管介入裝置市場：2012年

US Markets for Interventional Cardiology Devices 2012

價格 : US $ 5995

出版日期 : 2011年12月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!